McCormick F - Search Results

1

Evaluation of the selectivity and sensitivity of isoform- and mutation-specific RAS antibodies.

Waters AM, Ozkan-Dagliyan I, Vaseva AV, Fer N, Strathern LA, Hobbs GA, Tessier-Cloutier B, Gillette WK, Bagni R, Whiteley GR, Hartley JL, McCormick F, Cox AD, Houghton PJ, Huntsman DG, Philips MR, Der CJ. Waters AM, et al. Among authors: mccormick f. Sci Signal. 2017 Sep 26;10(498):eaao3332. doi: 10.1126/scisignal.aao3332. Sci Signal. 2017. PMID: 28951536 Free PMC article.

2

The COOH-terminal domain of the Rap1A (Krev-1) protein is isoprenylated and supports transformation by an H-Ras:Rap1A chimeric protein.

Buss JE, Quilliam LA, Kato K, Casey PJ, Solski PA, Wong G, Clark R, McCormick F, Bokoch GM, Der CJ. Buss JE, et al. Among authors: mccormick f. Mol Cell Biol. 1991 Mar;11(3):1523-30. doi: 10.1128/mcb.11.3.1523-1530.1991. Mol Cell Biol. 1991. PMID: 1899909 Free PMC article.

3

Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain.

Adari H, Lowy DR, Willumsen BM, Der CJ, McCormick F. Adari H, et al. Among authors: mccormick f. Science. 1988 Apr 22;240(4851):518-21. doi: 10.1126/science.2833817. Science. 1988. PMID: 2833817

4

Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Rodriguez-Viciana P, Sabatier C, McCormick F. Rodriguez-Viciana P, et al. Among authors: mccormick f. Mol Cell Biol. 2004 Jun;24(11):4943-54. doi: 10.1128/MCB.24.11.4943-4954.2004. Mol Cell Biol. 2004. PMID: 15143186 Free PMC article.

5

A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.

Rodriguez-Viciana P, Oses-Prieto J, Burlingame A, Fried M, McCormick F. Rodriguez-Viciana P, et al. Among authors: mccormick f. Mol Cell. 2006 Apr 21;22(2):217-30. doi: 10.1016/j.molcel.2006.03.027. Mol Cell. 2006. PMID: 16630891 Free article.

6

Ras signaling and therapies.

Young A, Lyons J, Miller AL, Phan VT, Alarcón IR, McCormick F. Young A, et al. Among authors: mccormick f. Adv Cancer Res. 2009;102:1-17. doi: 10.1016/S0065-230X(09)02001-6. Adv Cancer Res. 2009. PMID: 19595305 Review.

7

Dragging ras back in the ring.

Stephen AG, Esposito D, Bagni RK, McCormick F. Stephen AG, et al. Among authors: mccormick f. Cancer Cell. 2014 Mar 17;25(3):272-81. doi: 10.1016/j.ccr.2014.02.017. Cancer Cell. 2014. PMID: 24651010 Free article. Review.

8

The potential of targeting Ras proteins in lung cancer.

McCormick F. McCormick F. Expert Opin Ther Targets. 2015 Apr;19(4):451-4. doi: 10.1517/14728222.2014.1000304. Epub 2015 Jan 6. Expert Opin Ther Targets. 2015. PMID: 25558943

9

Farnesylated and methylated KRAS4b: high yield production of protein suitable for biophysical studies of prenylated protein-lipid interactions.

Gillette WK, Esposito D, Abreu Blanco M, Alexander P, Bindu L, Bittner C, Chertov O, Frank PH, Grose C, Jones JE, Meng Z, Perkins S, Van Q, Ghirlando R, Fivash M, Nissley DV, McCormick F, Holderfield M, Stephen AG. Gillette WK, et al. Among authors: mccormick f. Sci Rep. 2015 Nov 2;5:15916. doi: 10.1038/srep15916. Sci Rep. 2015. PMID: 26522388 Free PMC article.

10

K-Ras protein as a drug target.

McCormick F. McCormick F. J Mol Med (Berl). 2016 Mar;94(3):253-8. doi: 10.1007/s00109-016-1382-7. Epub 2016 Mar 9. J Mol Med (Berl). 2016. PMID: 26960760 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

591 results

Search Page